All Programs

Use the tool below to view all available Global Neurology Academy Series

The Role of B-Cell Depletion in MS Care
The Role of B-Cell Depletion in MS Care
NeuroFrontiers
The Role of B-Cell Depletion in MS Care
David Hafler, MD, FANA, MSc
- David Hafler, MD, FANA, MSc
The New Era of Targeted Therapy for Myasthenia Gravis
The New Era of Targeted Therapy for Myasthenia Gravis
NeuroFrontiers
The New Era of Targeted Therapy for Myasthenia Gravis
Shruti Raja, MD, MHS
- Shruti Raja, MD, MHS
Navigating Emerging Treatment Options in MG
Navigating Emerging Treatment Options in MG
NeuroFrontiers
Navigating Emerging Treatment Options in MG
Qihua Fan, MD
- Qihua Fan, MD
CME/CE In-Person Event
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
Multiple dates & locations available
1.00 credit
ADHD Medication Dose-Effect Patterns Vary by Age and Drug Class
ADHD Medication Dose-Effect Patterns Vary by Age and Drug Class
NeuroFrontiers
ADHD Medication Dose-Effect Patterns Vary by Age and Drug Class
ADHD Is Linked to a Broad Burden of GI Symptoms
ADHD Is Linked to a Broad Burden of GI Symptoms
NeuroFrontiers
ADHD Is Linked to a Broad Burden of GI Symptoms
ADHD After 25 Years: What Have We Learned?
ADHD After 25 Years: What Have We Learned?
NeuroFrontiers
ADHD After 25 Years: What Have We Learned?
James Swanson, PhD
- James Swanson, PhD
Diagnosing Adult ADHD in the Social Media Era
Diagnosing Adult ADHD in the Social Media Era
NeuroFrontiers
Diagnosing Adult ADHD in the Social Media Era
Jill RachBeisel, MD
- Jill RachBeisel, MD
Untangling ADHD from Depression, Anxiety, and Substance Use Disorder
Untangling ADHD from Depression, Anxiety, and Substance Use Disorder
NeuroFrontiers
Untangling ADHD from Depression, Anxiety, and Substance Use Disorder
Jill RachBeisel, MD
- Jill RachBeisel, MD
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
MinuteCE®
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 program credits
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 program credits
Recurrence as the Rule: BD Symptoms Persist and Cycle
Recurrence as the Rule: BD Symptoms Persist and Cycle
MinuteCE®
Recurrence as the Rule: BD Symptoms Persist and Cycle
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 program credits
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 program credits
Navigating the Limitations of Current BD Therapies
Navigating the Limitations of Current BD Therapies
MinuteCE®
Navigating the Limitations of Current BD Therapies
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 program credits
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 program credits
MinuteCE®
Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 credits 5 episodes
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 credits 5 episodes
Stroke-Like Symptoms During Treatment: Safety First
Stroke-Like Symptoms During Treatment: Safety First
MinuteCE®
Stroke-Like Symptoms During Treatment: Safety First
Dani Cabral, MD; David Weisman, MD
0.50 program credits
- Dani Cabral, MD
- David Weisman, MD
0.50 program credits
Borderline Biomarkers: When a Blood Test Is Not Enough
Borderline Biomarkers: When a Blood Test Is Not Enough
MinuteCE®
Borderline Biomarkers: When a Blood Test Is Not Enough
Dani Cabral, MD; David Weisman, MD
0.50 program credits
- Dani Cabral, MD
- David Weisman, MD
0.50 program credits
Antithrombotics and Amyloid Therapy: Balancing Risk
Antithrombotics and Amyloid Therapy: Balancing Risk
MinuteCE®
Antithrombotics and Amyloid Therapy: Balancing Risk
Dani Cabral, MD; David Weisman, MD
0.50 program credits
- Dani Cabral, MD
- David Weisman, MD
0.50 program credits

All Programs

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

All Programs

Popular

Title